Search Ontology:
ChEBI

formoterol

Term ID
CHEBI:5147
Synonyms
  • (+-)-2'-hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide
  • (+-)-formoterol
  • (R*,R*)-(+-)-N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide
  • formoterol
  • formoterolum
  • N-{2-hydroxy-5-[(1RS)-1-hydroxy-2-{[(2RS)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
  • rac-N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
Definition
A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).
References
  • CAS:73573-87-2
  • DrugBank:DB00983
  • KEGG:C07805
  • KEGG:D07990
  • Patent:DE2305092
  • Patent:US3994974
  • Reaxys:6741801
  • Wikipedia:Formoterol
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_part
has_role
inverse is_conjugate_acid_of
is_conjugate_base_of
Phenotype
Phenotype resulting from formoterol
Phenotype where environments contain formoterol
Phenotype modified by environments containing formoterol
Human Disease / Model Data